Kura Oncology, Inc. SEC filings KURA
Kura Oncology, Inc. has 806 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2026 | Sep 8, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2026 | Jul 24, 2026 |
| S-8 | Employee stock plan registration | Jun 4, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| DEFA14A | Additional proxy material | May 26, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 10, 2026 | — |
| DEF 14A | Proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 29, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Other events
|
Dec 2, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| S-8 | Employee stock plan registration | Nov 4, 2025 | — |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Other events
|
Oct 16, 2025 | Oct 15, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Other events
|
Jun 18, 2025 | Jun 12, 2025 |
| S-8 | Employee stock plan registration | Jun 6, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 1, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEF 14A | Proxy statement | Apr 11, 2025 | Jun 5, 2025 |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 14, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 6, 2025 | Jan 1, 2025 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 20, 2024 | Nov 20, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2024 | Sep 13, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| S-8 | Employee stock plan registration | Jun 7, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Other events
|
May 24, 2024 | May 24, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| ARS | Annual report to shareholders | Apr 18, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 12, 2024 | — |
| DEF 14A | Proxy statement | Apr 12, 2024 | Apr 12, 2024 |
| UPLOAD | Letter from the SEC | Feb 29, 2024 | — |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 424B3 | Prospectus | Feb 15, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 13, 2024 | — |
| S-3 | Shelf registration | Feb 9, 2024 | — |
| D | Filing | Feb 5, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 30, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 26, 2024 | Jan 24, 2024 |
| 8-K |
Current report
Other events
|
Dec 22, 2023 | Dec 18, 2023 |
| S-3ASR | Automatic shelf registration | Nov 2, 2023 | — |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement
|
Sep 1, 2023 | Aug 30, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Other events
|
Jun 14, 2023 | Jun 13, 2023 |
| 424B5 | Prospectus supplement | Jun 14, 2023 | — |
| 424B5 | Prospectus supplement | Jun 13, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 12, 2023 | Jun 11, 2023 |
| S-8 | Employee stock plan registration | Jun 2, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 2, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| DEFA14A | Additional proxy material | May 4, 2023 | — |
| ARS | Annual report to shareholders | Apr 20, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Apr 19, 2023 | Apr 18, 2023 |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| S-8 | Employee stock plan registration | Feb 24, 2023 | — |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| CT ORDER | Filing | Feb 21, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Jan 13, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Dec 12, 2022 | Dec 10, 2022 |
| 8-K |
Current report
Other events
|
Nov 3, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Nov 3, 2022 | Nov 2, 2022 |
| 424B5 | Prospectus supplement | Nov 3, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2022 | Sep 26, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 21, 2022 |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 21, 2022 |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Feb 24, 2022 | Feb 24, 2022 |
| 424B5 | Prospectus supplement | Feb 24, 2022 | — |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 1, 2022 | Jan 26, 2022 |
| 8-K |
Current report
Other events
|
Jan 20, 2022 | Jan 20, 2022 |
| 8-K |
Current report
Other events
|
Nov 24, 2021 | Nov 24, 2021 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2021 | Jul 28, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2021 | Jun 22, 2021 |
| DEFA14A | Additional proxy material | Jun 4, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Agreement ended
|
May 24, 2021 | May 19, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
May 17, 2021 | May 11, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 22, 2021 |
| S-8 | Employee stock plan registration | Feb 24, 2021 | — |
| 10-K | Annual report | Feb 24, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2021 | Feb 24, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 8, 2021 | Jan 4, 2021 |
| 8-K |
Current report
Other events
|
Dec 9, 2020 | Dec 8, 2020 |
| 424B5 | Prospectus supplement | Dec 9, 2020 | — |
| 424B5 | Prospectus supplement | Dec 7, 2020 | — |
| S-3ASR | Automatic shelf registration | Dec 7, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 7, 2020 | Dec 5, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2020 | Nov 4, 2020 |
| 424B3 | Prospectus | Aug 19, 2020 | — |
| EFFECT | Filing | Aug 18, 2020 | — |
| CORRESP | Letter to the SEC | Aug 14, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2020 | — |
| S-3 | Shelf registration | Aug 6, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Other events
|
May 29, 2020 | May 29, 2020 |
| 8-K |
Current report
Other events
|
May 6, 2020 | May 5, 2020 |
| 424B5 | Prospectus supplement | May 6, 2020 | — |
| 424B5 | Prospectus supplement | May 5, 2020 | — |
| 10-Q | Quarterly report | May 4, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 4, 2020 | May 4, 2020 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 24, 2020 | Apr 22, 2020 |
| 8-K |
Current report
Material agreement
|
Apr 7, 2020 | Apr 3, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 26, 2020 | Mar 24, 2020 |
| CT ORDER | Filing | Mar 17, 2020 | — |
| CT ORDER | Filing | Mar 17, 2020 | — |
| CT ORDER | Filing | Mar 17, 2020 | — |
| 8-K |
Current report
Other events
|
Mar 4, 2020 | Mar 3, 2020 |
| S-8 | Employee stock plan registration | Feb 25, 2020 | — |
| 10-K | Annual report | Feb 25, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2020 | Feb 25, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2020 | Jan 23, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 10, 2020 | Jan 8, 2020 |
| 8-K |
Current report
Other events
|
Dec 16, 2019 | Dec 16, 2019 |
| 8-K |
Current report
Other events
|
Dec 9, 2019 | Dec 8, 2019 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2019 | Nov 5, 2019 |
| 8-K |
Current report
Other events
|
Oct 30, 2019 | Oct 29, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2019 | Oct 14, 2019 |
| 8-K |
Current report
Other events
|
Sep 3, 2019 | Sep 3, 2019 |
| EFFECT | Filing | Aug 28, 2019 | — |
| 424B3 | Prospectus | Aug 28, 2019 | — |
| CORRESP | Letter to the SEC | Aug 26, 2019 | — |
| CORRESP | Letter to the SEC | Aug 21, 2019 | — |
| S-3/A | Filing | Aug 21, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2019 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 12, 2019 | Aug 9, 2019 |
| S-3 | Shelf registration | Aug 1, 2019 | — |
| 10-Q | Quarterly report | Aug 1, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2019 | Aug 1, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2019 | Jun 25, 2019 |
| 8-K |
Current report
Other events
|
Jun 19, 2019 | Jun 18, 2019 |
| 424B5 | Prospectus supplement | Jun 19, 2019 | — |
| 424B5 | Prospectus supplement | Jun 18, 2019 | — |
| 8-K |
Current report
Other events
|
Jun 14, 2019 | Jun 14, 2019 |
| 10-Q | Quarterly report | May 7, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 25, 2019 |
| S-8 | Employee stock plan registration | Mar 5, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1422143
- Former names
- ZETA ACQUISITION CORP III (until Mar 10, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.